KCT0003190
Completed
未知
A multicenter, prospective, non-interventional observational study to determine LDL-C goal attainment rate in elderly patients with dyslipidemia receiving Mevalotin® Tab.
Daiichi-Sankyo Korea0 sites3,000 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Daiichi-Sankyo Korea
- Enrollment
- 3000
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Males or females aged \= 65 years with a diagnosis of dyslipidemia
- •2\. Patients who were prescribed Mevalotin® in the judgment of their physicians, or who started receiving Mevalotin® tab. within 6 weeks from enrollment in this observational study
- •3\. Voluntary written consent to participation in this observational study by the patients or their representatives
Exclusion Criteria
- •There will be no particular exclusion criteria.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A prospective, non-interventional, multicenter, observational study to investigate the effectiveness and safety of Sevikar HCT® Tablet in hypertensive patients with type 2 diabetes mellitus or prediabetes in KoreaDiseases of the circulatory systemKCT0006918Daiichi-Sankyo Korea3,000
Recruiting
Not Applicable
Multicenter, non-interventional, prospective observational study to investigate the local treatment of chemotherapy-induced peripheral neuropathy with QUTENZA in breast cancer patientsG62.0Drug-induced polyneuropathyDRKS00022442Grünenthal GmbH German Sales Division77
Completed
Not Applicable
A non-interventional, prospective, multicenter study to describe patient preference and real-world outcomes of Diroximel Fumarate for the treatment of relapsing remitting multiple sclerosis in daily clinical practiceG35.1DRKS00029567Biogen GmbH118
Recruiting
Not Applicable
Multi-center, Prospective, Non-interventional, Observational Cohort Study to Investigate Effectiveness and Safety of Rivaroxaban on Prevention of Stroke and Systemic Embolism in Patients with Non-valvular Atrial Fibrillation in Japanese Clinical Practiceon-valvular atrial fibrillation (In the present study, non-valvular atrial fibrillation refers to atrial fibrillation without a history of prosthetic valve replacement or mitral valve stenosis.)JPRN-UMIN000009376Tohoku University School of Medicine7,000
Completed
Not Applicable
This is an observational study conducted to observe how subjects with dizziness and dizziness associated symptoms are managed in primary care setting in India.Health Condition 1: G89-G99- Other disorders of the nervous systemCTRI/2018/11/016408Abbott Healthcare Private Ltd1,000